Arena Pharmaceuticals, Inc. is a biopharmaceutical company founded in 1997 and located in San Diego, California. The company has small molecule drugs in development for possible clinical utility in multiple therapeutic areas. The company’s most advanced investigational clinical programs are ralinepag (formerly APD811) in testing for pulmonary arterial hypertension (PAH), etrasimod (formerly APD334) in evaluation for inflammatory indications and APD371 for the treatment of pain associated with Crohn’s disease. In 2016 the company downsized and shifted its focus to developing new drugs currently being tested in clinical trials.

Suven Life Sciences Limited, a research-based biopharmaceutical company, designs, manufactures, and supplies bulk actives, drug intermediates, and fine chemicals for the life science industry worldwide. It provides advanced intermediates, intermediates, and active pharmaceutical ingredients. The company also offers contract research and manufacturing services, including development and supply of pharmaceutical and agro chemical intermediates for new chemical entities.

Grünenthal GmbH engages in the research and development of pharmaceutical products. It specializes in pain, gout, and inflammation. The company was founded by Hermann Wirtz in 1946 and is headquartered in Aachen, Germany.

Eli Lilly engages in the discovery, development, manufacture, and sale of products in the pharmaceutical products business segment. The company manufactures and distributes products through owned or leased facilities in the United States, Puerto Rico, and 25 other countries. Its products are sold in approximately 135 countries. It also conducts research to find products to treat diseases in animals and to increase the efficiency of animal food production.

Vanda Pharmaceuticals, Inc. engages in the development and commercialization of therapies for high unmet medical needs. The firm intends to treat schizophrenia, jet lag disorder, atopic dermatitis, central nervous system disorders, and circadian rhythm sleep disorder. Its product portfolio includes HETLIOZ, Fanapt, Tradipitant, Trichostatin, and AQW051. The company was founded by Mihael Hristos Polymeropoulos and Argeris N. Karabelas in 2002 and is headquartered in Washington, DC.

Adamas Pharma LLC manufactures pharmaceutical products. The company is headquartered in Emeryville, CA.

Elan Pharma International Ltd., a subsidiary of Perrigo Co. Plc, is a company headquartered in South San Francisco, CA, that develops, manufactures and distributes pharmaceutical products.

Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring, and developing small molecules and biologics to treat and prevent human disease and alleviate suffering. Tonix’s portfolio is primarily composed of the central nervous system (CNS) and immunology product candidates. The CNS portfolio includes both small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions.

TCI Co., Ltd. engages in the research, development, manufacturing, and sales of health foods and care products. The firm's products include function drinks for beauty, slim, health and energy, function foods in double-layered tablets, capsules, microencapsulated beads and sachet, cosmetics and care products, including creams, bio-cellulose masks, sprays and mousses, and dietary supplements. It operates through the following geographical segments: Taiwan, Asia, and Other. The company was founded on August 22, 1980 and is headquartered in Taipei, Taiwan.

Develops innovative products for the treatment of a variety of human diseases

Intra-Cellular Therapies (ITI) is developing novel drugs for the treatment of neuropsychiatric and neurologic diseases and other disorders of the Central Nervous System (CNS). We combine the efforts of medicinal chemists, pharmacologists, biologists and clinical development scientists into a vibrant team that translates world-class research expertise into novel drugs. The company's lead product, ITI-007 is a novel first-in-class 5-HT2A antagonist, Dopamine receptor phosphoprotein modulator (DPPM) designed to treat multiple deficits in patients with schizophrenia while lacking the side-effects of existing antipsychotic drugs. ITI has also developed a state of the art technology platform, called CNSProfile™ that is capable of generating a unique molecular signature for drug compounds. This profile provides us with a proprietary window into the intracellular action of CNS drugs or drug candidates. We use this tool to fingerprint the intracellular molecular actions of existing drugs and to drive our internal drug discovery and development. Our technology has also enabled the company to examine the toxic effects of brain damaging nerve agents, and as a result, we are involved in collaborative efforts with several military and contract organizations to develop antidotes to chemical warfare agents. Based upon our understanding of the Central Nervous System we have discovered novel drug candidates with promise for treating the panoply of symptoms associated with the transition from peri-menopausal to post-menopausal states. Intra-Cellular Therapies was founded in 2002 by Drs. Paul Greengard, Sharon Mates and Allen Fienberg. The company is headquartered in New York City.

Solar Light Co., Inc. engages in manufacturing of precision ultraviolet light sources, solar simulators, and radiometers. The firm provides accelerated ultraviolent testing and light source spectral measurement services. Its products include light sensors, light meters and transmittance analyzers. The company was founded in 1967 and is headquartered in Glenside, PA.

Pfizer Inc. (NYSE: PFE, /ˈfaɪzər/) is an American multinational pharmaceutical corporation headquartered in New York City was founded in 1849, based in New York City and was listed on New York Stock Exchange. It is one of the world's largest pharmaceutical companies. It is listed on the New York Stock Exchange, and its shares have been a component of the Dow Jones Industrial Average since 2004. Pfizer ranked No. 57 on the 2018 Fortune 500 list of the largest United States corporations by total revenue.

Guojian Pharmaceutical (Shenzhen) Group Co., Ltd., established on 2004-06-29, Business scope includes general business items:Business Management Consulting;Venture Capital Business Consulting;Business Consulting(No restricted items);Enterprise Marketing Planning;Exhibition planning;in the advertising business(laws and regulations,The State Council stipulates that it is necessary to separately handle the approval of advertising business,Licensed to operate);Chinese medicine technology development;Chinese herbal medicine planting;Technical development of traditional Chinese medicine products,technology transfer;Class I medical device sales;Health and wellness management consulting(Does not contain medical behavior);Chinese medicine research and development;Medical technology research and development,technology transfer,technical consulting,Technical Services;Medical data management and analysis,Technology development of smart medical system;Sales of cosmetics and hygiene products;Provide logistics management services for medical institutions;Engaged in technology development in the field of biotechnology products,technical consulting,technology transfer,Technical Services;Technical research and development of biological products;Biological Antibody Research;Research and development of health products;Project investment and planning;Medical Experimental Research;Human Science Research;Stem Cell Technology Research;drug development;Gene drug development;Stem Cell Drug Development;Technology research and development of medical devices and equipment,Sales and Leasing;Engaged in technology development in life sciences,technical consulting,technology transfer,Technical Services;Invest in the dental industry;Hospital,the medical,Investment in pension projects(Specific projects will be reported separately);Digital point management system development;Design and event planning of digital point exchange product scheme;Consumption general point system,Member Points Management System,Technology development and management of city card point value-added system;Investment in health industry projects(Specific projects will be reported separately);Blockchain technology development;Data Processing and Storage Services;database management;Artificial intelligence technology research and development,technical consulting,Technical service and technology transfer;Internet technology development(Does not include Internet access);Domestic Trade;Operating import and export business;Chinese Medicine Information Consultation;Medical Industry Investment;Planning of medical academic exchange activities;car sales;Automotive technology development and related technical consulting,technical maintenance;battery acquisition.,The licensing program is:Chinese patent medicine,Chinese herbal medicine,Chinese Herbal Medicine,Chemicals,Chemical API,antibiotics,Wholesale of biochemical drugs;Business Class II:Basic Surgical Instruments,General diagnostic equipment,Chinese medicine equipment,Medical testing and basic equipment,Ward Nursing Equipment and Appliances,Disinfection and sterilization equipment and utensils;two,Three categories:Medical Ultrasonic Instruments and Related Equipment,Physiotherapy and Rehabilitation Equipment,operating room,emergency room,Treatment room equipment and appliances,Medical hygiene materials and dressings,Medical Suture Materials and Adhesives,Medical polymer materials and products(single use infusion(Blood)device(Needle)class except);Health food wholesale(Restricted Regulatory Intestinal Class,Nutrient Supplements,Boost immunity);Pre-packaged food(Without reheating),bulk food(Does not contain cooked food,non alcoholic beverages)wholesale;Health food sales;Provide medical and health human resources management services,engaged in medical services(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments);TCM diagnosis and treatment services;sales of traditional Chinese medicine;Class II medical device business;Class III medical device business;food production;R&D and sales of formula food for special medical purposes;Research and development and sales of food for special dietary use.Chinese Herbal Pieces Decoction Service.(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments,The specific business items are subject to the approval documents or licenses of relevant departments)

Part of Idorsia Ltd., Idorsia Pharmaceuticals Ltd. is a company headquartered in Allschwil, Switzerland. The firm develops and commercializes pharmaceuticals. Jean-Paul Clozel is the current CEO, occupying that position since 2017.\nThe company says this about itself: Headquartered near Basel, Switzerland - a biotech-hub of Europe-Idorsia is specialized in the discovery and development of small molecules, to transform the horizon of therapeutic options. Idorsia has a broad portfolio of innovative drugs in the pipeline, an experienced team of over 700 highly qualified specialists dedicated to realizing our ambitious targets, a fully functional research center, and a strong balance sheet – the ideal constellation to bringing R&D efforts to business success.

Société des Produits Nestlé SA engages in the manufacture and distribution of food, pharmaceutical, medical, and cosmetic products. The company was founded on December 15, 1936 and is headquartered in Vevey, France.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud, and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.